MCP
AGN

Moab Capital Partners’s Allergan plc AGN Stock Holding History

Moab Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-133,121
Closed -$23.6M – 25
2020
Q1 		$23.6M Buy
133,121
+17,943
+16% +$3.38M 9.8% 3
2019
Q4 		$22M Sell
115,178
-6,822
-6% -$1.23M 8.7% 4
2019
Q3 		$20.5M Buy
122,000
+77,000
+171% +$12.5M 7.81% 3
2019
Q2 		$7.53M Buy
+45,000
New +$6.23M 2.45% 13
2016
Q2 		– Sell
-26,100
Closed -$7M – 35
2016
Q1 		$7M Buy
+26,100
New +$7.47M 2.45% 10

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Moab Capital Partners's AGN Position: Q2 2020 in Review

Moab Capital Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 133,121 shares — an estimated $23.6M sold.

Moab Capital Partners first reported a position in AGN in Q1 2016 and held it in 5 quarters. The position peaked at $23.6M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Moab Capital Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Moab Capital Partners sold 133,121 Allergan plc shares in Q2 2020, an estimated $23.6M.
  • Moab Capital Partners first reported a position in Allergan plc in Q1 2016 and held it in 5 quarters.
  • Moab Capital Partners's Allergan plc position peaked at $23.6M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Moab Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.